Table 1.
Characteristics of participants who completed the assessments at Time1, Time2, and Time3
| Variable | T1 n (%); N = 31 | T2 n (%) ; N = 24 | T3 n (%) ; N = 13 |
|---|---|---|---|
| Age (mean ±SD) 55.96 (±11.64) | |||
| 18–30 | 1 (3.2) | 1 (4.5) | 1 (6.7) |
| 31–45 | 5 (16.1) | 5 (22.7) | 2 (13.3) |
| 46–60 | 12 (38.7) | 8 (36.4) | 6 (40.0) |
| 61–75 | 13 (41.9) | 8 (36.4) | 6 (40.0) |
| Highest level of education | |||
| High School | 5 (16.1) | 3 (13.6) | 2 (13.3) |
| College | 14 (45.2) | 10 (45.5) | 8 (53.3) |
| University | 12 (38.7) | 9 (40.9) | 5 (33.3) |
| Ethnicity | |||
| Caucasian | 31 (93.9) | 21 (91.3) | 15 (100.0) |
| African | 1 (3.0) | 1 (4.3) | 0 (0) |
| Asian | 1 (3.0) | 1 (4.3) | 0 (0) |
| Marital Status | |||
| Married/common law | 22 (71.0) | 17 (77.3) | 12 (80.0) |
| Single/Divorced/widowed | 9 (29.0) | 5 (22.7) | 3 (20.0) |
| Employment Status | |||
| Employed (Fulltime/part-time) | 6 (20.0) | 6 (28.6) | 4 (28.6) |
| Unemployed | 24 (80.0) | 15 (71.4) | 10 (71.4) |
| Primary GI Tumour type | |||
| Colorectal | 19 (57.6) | 14 (60.9) | 11 (73.3) |
| Esophageal | 2 (6.1) | 1 (4.3) | 1 (6.7) |
| Stomach | 1 (3.0) | 1 (4.3) | 1 (6.7) |
| Pancreatic | 6 (18.2) | 3 (13.0) | 1 (6.7) |
| Liver | 1 (3.0) | 1 (4.3) | 0(0) |
| Bile duct | 1 (3.0) | 1 (4.3) | 0(0) |
| Tumour stage | |||
| 1 | 2 (8.3) | 2 (10.0) | 2 (15.4) |
| 2 | 3 (12.5) | 3 (15.0) | 2 (15.4) |
| 3 | 6 (25.0) | 5 (25.0) | 5 (38.5) |
| 4 | 13 (54.2) | 10 (50.0) | 4 (30.8) |
| Time since diagnosis | |||
| ≤6 months | 13 (44.8) | 8 (38.1) | 5 (35.7) |
| 6.1–12 months | 7 (24.1) | 6 (28.6) | 3 (21.4) |
| 12.1–18 months | 3(10.3) | 3 (14.3) | 2 (14.3) |
| 18.1–24 months | 3(10.3) | 1 (4.80 | 1 (7.1) |
| >24 months | 3(10.3) | 3 (14.3) | 5 (21.4) |
| Multiple cancer diagnoses | |||
| No | 23 (74.2) | 17 (77.3) | 11 (73.3) |
| Yes | 8 (25.8) | 5 (22.7) | 4 (26.7) |
| Current treatment | |||
| Surgery | 5 (16.1) | 4 (18.2) | 3 (20.0) |
| Chemotherapy | 19 (61.3) | 12 (54.5) | 7 (46.7) |
| Radiation therapy | 1 (3.2) | 1 (4.5) | 1 (6.7) |
| Upcoming treatment | 1 (3.2) | 1 (4.5) | – |
| Past treatment | |||
| Surgery | 16 (48.5) | 11 (50.0) | 9 (60.0) |
| Chemotherapy | 10 (32.3) | 9 (40.9) | 8 (53.3) |
| Radiation therapy | 6 (19.4) | 5 (22.7) | 5 (33.3) |
*T1 = baseline, T2 = 3 months and T3 = 6 months
N, total number of participants